Fig. 2. Endodermal WNT-β-catenin signaling is required for GT
initiation. (A-C) SEM analysis showing an absence of GT outgrowth
in the Shhcre/Gfp;β-Catc/c embryo
(B) and a larger GT in the
Shhcre/Gfp;β-CatloxEx3 embryo
(C). (D-F) β-Catenin indirect immunoflouresence showing that the
protein was detected mainly on the cell membranes of both GT ectoderm and UE,
as well as weakly in the mesechyme (D). Complete removal of β-catenin in
the UE was confirmed in
Shhcre/Gfp;β-Catc/c GT (arrows,
E), and ectopic accumulation of β-catenin was observed in
Shhcre/Gfp;β-CatloxEx3 endoderm
(arrow, F). (G-I) Whole-mount Fgf8 in situ hybridization
showing expression in the distal cloacal endoderm in control embryos (G), but
not in Shhcre/Gfp;β-Catc/c
embryos (arrows, H); in
Shhcre/Gfp;β-CatloxEx3 GT,
Fgf8 expression is ectopically expanded (I). (J,K)
Whole-mount Bmp4 in situ hybridization showing a reduction in
Shhcre/Gfp;β-Catc/c cloacal
mesenchyme (K). (M-O) TUNEL analysis showing increased cell death in
Shhcre/Gfp;β-Catc/c cloacal
endoderm and ectopic apoptotic cells in the surrounding mesenchyme (arrows in
N). (P-R) PHH3 immunostaining revealing markedly reduced cell
proliferation in E10.5
Shhcre/Gfp;β-Catc/c cloacal
endoderm. (S-U,W,X) Fgf8 in situ hybridization
showing an absence of expression in E10.5
Msx2-Cre;β-Catc/c limbs (T) and ectopic
expression in the flank ectoderm and dorsal limb ectoderm in
Msx2-cre;β-CatloxEx3 embryos (U). (V)
Note that ectopic Fgf8 expression appears to correspond to
Msx2-Cre expression (arrows in U,V). At E12.5, ectopic outgrowth was
observed in the inter-limb region of
Msx2-Cre;β-CatloxEx3 embryos (arrows, X).
Scale bars: 100 µm in A-F; 50 µm in M,N,P,Q.